Merck & Co. Inc. Earnings

Merck & Co. Inc.’s revenue fell -1.9% since last year same period to $15806Mn in the Q2 2025. On a quarterly growth basis, Merck & Co. Inc. has generated 1.78% jump in its revenue since last 3-months.

Merck & Co. Inc.’s net profit fell -18.85% since last year same period to $4427Mn in the Q2 2025. On a quarterly growth basis, Merck & Co. Inc. has generated -12.84% fall in its net profits since last 3-months.

Merck & Co. Inc.’s net profit margin fell -17.27% since last year same period to 28.01% in the Q2 2025. On a quarterly growth basis, Merck & Co. Inc. has generated -14.36% fall in its net profit margins since last 3-months.

Merck & Co. Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.44 - a 18.45% jump from last quarter’s estimates.

Merck & Co. Inc.’s earning per share (EPS) estimates for the current year stand at 2.44.

Merck & Co. Inc.’s earning per share (EPS) fell -6.58% since last year same period to 2.13 in the Q2 2025. This indicates that the Merck & Co. Inc. has generated -6.58% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Merck & Co. Inc. declared 0.81 dividend per share during the earnings announcement for Q2 2025.